当前位置: X-MOL 学术Pediatr. Blood Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial germinoma during the COVID-19 pandemic
Pediatric Blood & Cancer ( IF 2.4 ) Pub Date : 2021-09-14 , DOI: 10.1002/pbc.29359
Matthew J Murray 1, 2 , Rafael Moleron 3 , Jennifer Adamski 4 , Martin English 4 , G A Amos Burke 2 , Justin Cross 5 , Thankamma Ajithkumar 6 , Sara Stoneham 7 , James C Nicholson 2
Affiliation  

Patientswith localized intracranial germinoma have excellent survival. Reducing treatment burden and long-term sequelae is a priority. Intensive inpatient chemotherapy (e.g., carboPEI = carboplatin/etoposide/ifosfamide) has been effectively employed to reduce radiotherapy treatment volume/dose. Outpatient-based carboplatin monotherapy is associated with excellent outcomes in metastatic testicular seminoma (an identical pathology), and successful vinblastine monotherapy induction (with 77% tumor volume reduction after just two weekly vinblastine doses) has recently been reported in an intracranial germinoma patient.

中文翻译:

COVID-19 大流行期间颅内生殖细胞瘤患者在放疗前诱导长春碱单药治疗

局限性颅内生殖细胞瘤患者的生存率极好。减轻治疗负担和长期后遗症是当务之急。强化住院化疗(例如,carboPEI = 卡铂/依托泊苷/异环磷酰胺)已被有效地用于减少放疗治疗量/剂量。基于门诊的卡铂单药治疗与转移性睾丸精原细胞瘤(相同的病理)的良好结果相关,最近在颅内生殖细胞瘤患者中报道了成功的长春碱单药治疗诱导(仅每周两次长春碱剂量后肿瘤体积减少 77%)。
更新日期:2021-09-14
down
wechat
bug